Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Annona squamosa ethanolic extract (AnsTE) is a botanical extract derived from the fruits of *Annona squamosa* L., commonly known as sugar apple or custard apple. It contains a variety of bioactive compounds, primarily annonaceous acetogenins and ent-kaurane diterpenes. Research indicates that the extract possesses significant anticancer properties, demonstrating cytotoxicity against various human cancer cell lines, including cervical (HeLa), prostate (PC3), and ovarian (SKOV3) adenocarcinoma. Its mechanism of action involves the induction of apoptosis and cell cycle arrest in the S phase. Additionally, the extract has been utilized in the biogenic synthesis of silver nanoparticles (Ans-AgNPs), which exhibit enhanced antibacterial and antifungal activities. Molecular docking studies suggest potential interactions with Bcl-2 proteins, further supporting its role in promoting programmed cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on annona squamosa ethanolic extract.